117 related articles for article (PubMed ID: 19002011)
1. Successful treatment of hypereosinophilic syndrome with cyclosporine.
Donald CE; Kahn MJ
Am J Med Sci; 2009 Jan; 337(1):65-6. PubMed ID: 19002011
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclosporine on lymphocytic variant hypereosinophilic syndrome.
Tabata R; Tabata C; Katashima Y; Yasumizu R
Int Immunopharmacol; 2013 Aug; 16(4):488-91. PubMed ID: 23669338
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of hypereosinophilic syndrome with cyclosporin and steroids].
Akiyama Y; Shimizu A; Kimura A; Onodera R; Minatani M; Horikoshi K; Jingu K; Fukakusa M; Kotajima F; Sato T
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):541-5. PubMed ID: 9234632
[TBL] [Abstract][Full Text] [Related]
4. [Hypereosinophilic syndrome with DIC treated successfully with a combination of high-dose methylprednisolone and cyclosporin A].
Fukuta A; Hara T; Tsurumi H; Moriwaki H
Rinsho Ketsueki; 2001 Nov; 42(11):1145-7. PubMed ID: 11808087
[TBL] [Abstract][Full Text] [Related]
5. Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis.
Williams AK; Dou C; Chen LYC
Br J Haematol; 2021 Dec; 195(5):669-680. PubMed ID: 34105142
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T-cell abnormality.
Nadarajah S; Krafchik B; Roifman C; Horgan-Bell C
Pediatrics; 1997 Apr; 99(4):630-3. PubMed ID: 9093318
[No Abstract] [Full Text] [Related]
7. Lymphocytic variant of hypereosinophilic syndrome.
Zaheri S; Alam A; Marks AJ; Wakelin S
Clin Exp Dermatol; 2010 Aug; 35(6):634-6. PubMed ID: 20236287
[TBL] [Abstract][Full Text] [Related]
8. Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.
Roufosse F; de Lavareille A; Schandené L; Cogan E; Georgelas A; Wagner L; Xi L; Raffeld M; Goldman M; Gleich GJ; Klion A
J Allergy Clin Immunol; 2010 Oct; 126(4):828-835.e3. PubMed ID: 20810155
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic hypereosinophilic syndrome in a patient with long-standing rheumatoid arthritis: a case report.
Chaudhuri K; Dubey S; Zaphiropoulos G
Rheumatology (Oxford); 2002 Mar; 41(3):349-50. PubMed ID: 11934978
[No Abstract] [Full Text] [Related]
10. The proportion of CD3- CD4+ T-cell population remained unaffected after corticosteroids treatment for lymphocytic variant hypereosinophilic syndrome (L-HES).
Helbig G; Wichary R; Razny M; Rodzaj M; Wozniczka K; Dziaczkowska-Suszek J; Kyrcz-Krzemien S
Scand J Immunol; 2010 Oct; 72(4):372-3. PubMed ID: 20883323
[No Abstract] [Full Text] [Related]
11. An 8-year-old boy with hypereosinophilic syndrome.
Hosoki K; Nagao M; Iguchi K; Ihara T; Yamada Y; Higashigawa M; Kephart GM; Kita H; Fujisawa T
Int Arch Allergy Immunol; 2011; 155 Suppl 1():117-22. PubMed ID: 21646806
[TBL] [Abstract][Full Text] [Related]
12. Hypereosinophilic syndrome: progression of peripheral neuropathy despite controlled eosinophil levels.
Cengiz B; Sucak G; Kuruoğlu R; Tan E
Acta Neurol Belg; 1999 Jun; 99(2):133-7. PubMed ID: 10427356
[TBL] [Abstract][Full Text] [Related]
13. [Idiopathic hypereosinophilic syndrome associated with rheumatoid arthritis. A case report].
Bonanno D; Fedele R; Minciullo P; Quattrocchi P; Ferlazzo B
Reumatismo; 2003; 55(3):181-3. PubMed ID: 14513118
[TBL] [Abstract][Full Text] [Related]
14. [Endomyocardial disease as the first manifestation of hypereosinophilic syndrome].
Poreba M; Rostoff P; Konduracka E; Pikul P; Rucińska M; Pasowicz M; Piwowarska W
Kardiol Pol; 2010 Apr; 68(4):440-5. PubMed ID: 20425707
[TBL] [Abstract][Full Text] [Related]
15. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.
Schwartz LB; Sheikh J; Singh A
Curr Med Res Opin; 2010 Aug; 26(8):1933-46. PubMed ID: 20565230
[TBL] [Abstract][Full Text] [Related]
16. The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.
Lefèvre G; Copin MC; Staumont-Sallé D; Avenel-Audran M; Aubert H; Taieb A; Salles G; Maisonneuve H; Ghomari K; Ackerman F; Legrand F; Baruchel A; Launay D; Terriou L; Leclech C; Khouatra C; Morati-Hafsaoui C; Labalette M; Borie R; Cotton F; Gouellec NL; Morschhauser F; Trauet J; Roche-Lestienne C; Capron M; Hatron PY; Prin L; Kahn JE;
Medicine (Baltimore); 2014 Oct; 93(17):255-266. PubMed ID: 25398061
[TBL] [Abstract][Full Text] [Related]
17. Hypereosinophilic syndrome: case presentation and update.
Leiferman KM; Gleich GJ
J Allergy Clin Immunol; 2004 Jan; 113(1):50-8. PubMed ID: 14713907
[TBL] [Abstract][Full Text] [Related]
18. Mucosal ulcerations revealing primitive hypereosinophilic syndrome.
Barouky R; Bencharif L; Badet F; Salles G; Vital Durand D; Rousset H
Eur J Dermatol; 2003; 13(2):207-8. PubMed ID: 12695143
[TBL] [Abstract][Full Text] [Related]
19. [Neurologic complications in hypereosinophilia syndrome--a case report].
Otto V
Fortschr Neurol Psychiatr; 1993 Sep; 61(9):310-2. PubMed ID: 7693561
[TBL] [Abstract][Full Text] [Related]
20. CD30+ clonal T-cell lymphoid proliferation of the skin in a patient with hypereosinophilic syndrome.
Kempf W; Kazakov DV; Szep Z; Vanecek T
J Cutan Pathol; 2015 Feb; 42(2):130-5. PubMed ID: 25421540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
